Cargando…

Establishment of a dynamic nomogram including thyroid function for predicting the prognosis of acute ischemic stroke with standardized treatment

PURPOSE: Many patients with acute ischemic stroke (AIS) cannot undergo thrombolysis or thrombectomy because they have missed the time window or do not meet the treatment criteria. In addition, there is a lack of an available tool to predict the prognosis of patients with standardized treatment. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yi, Xie, Chunhui, Zhang, Guanghui, Liu, Mengqian, Xu, Yiwen, Zhong, Wen, Ge, Zhonglin, Tao, Zhonghai, Qian, Mingyue, Gong, Chen, Shen, Xiaozhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311209/
https://www.ncbi.nlm.nih.gov/pubmed/37396756
http://dx.doi.org/10.3389/fneur.2023.1139446
_version_ 1785066693907709952
author Jiang, Yi
Xie, Chunhui
Zhang, Guanghui
Liu, Mengqian
Xu, Yiwen
Zhong, Wen
Ge, Zhonglin
Tao, Zhonghai
Qian, Mingyue
Gong, Chen
Shen, Xiaozhu
author_facet Jiang, Yi
Xie, Chunhui
Zhang, Guanghui
Liu, Mengqian
Xu, Yiwen
Zhong, Wen
Ge, Zhonglin
Tao, Zhonghai
Qian, Mingyue
Gong, Chen
Shen, Xiaozhu
author_sort Jiang, Yi
collection PubMed
description PURPOSE: Many patients with acute ischemic stroke (AIS) cannot undergo thrombolysis or thrombectomy because they have missed the time window or do not meet the treatment criteria. In addition, there is a lack of an available tool to predict the prognosis of patients with standardized treatment. This study aimed to develop a dynamic nomogram to predict the 3-month poor outcomes in patients with AIS. METHODS: This was a retrospective multicenter study. We collected the clinical data of patients with AIS who underwent standardized treatment at the First People's Hospital of Lianyungang from 1 October 2019 to 31 December 2021 and at the Second People's Hospital of Lianyungang from 1 January 2022 to 17 July 2022. Baseline demographic, clinical, and laboratory information of patients were recorded. The outcome was the 3-month modified Rankin Scale (mRS) score. The least absolute shrinkage and selection operator regression were used to select the optimal predictive factors. Multiple logistic regression was performed to establish the nomogram. A decision curve analysis (DCA) was applied to assess the clinical benefit of the nomogram. The calibration and discrimination properties of the nomogram were validated by calibration plots and the concordance index. RESULTS: A total of 823 eligible patients were enrolled. The final model included gender (male; OR 0.555; 95% CI, 0.378–0.813), systolic blood pressure (SBP; OR 1.006; 95% CI, 0.996–1.016), free triiodothyronine (FT3; OR 0.841; 95% CI, 0.629–1.124), National Institutes of Health stroke scale (NIHSS; OR 18.074; 95% CI, 12.264–27.054), Trial of Org 10172 in Acute Stroke Treatment (TOAST; cardioembolic (OR 0.736; 95% CI, 0.396–1.36); and other subtypes (OR 0.398; 95% CI, 0.257–0.609). The nomogram showed good calibration and discrimination (C-index, 0.858; 95% CI, 0.830–0.886). DCA confirmed the clinical usefulness of the model. The dynamic nomogram can be obtained at the website: predict model (90-day prognosis of AIS patients). CONCLUSION: We established a dynamic nomogram based on gender, SBP, FT3, NIHSS, and TOAST, which calculated the probability of 90-day poor prognosis in AIS patients with standardized treatment.
format Online
Article
Text
id pubmed-10311209
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103112092023-07-01 Establishment of a dynamic nomogram including thyroid function for predicting the prognosis of acute ischemic stroke with standardized treatment Jiang, Yi Xie, Chunhui Zhang, Guanghui Liu, Mengqian Xu, Yiwen Zhong, Wen Ge, Zhonglin Tao, Zhonghai Qian, Mingyue Gong, Chen Shen, Xiaozhu Front Neurol Neurology PURPOSE: Many patients with acute ischemic stroke (AIS) cannot undergo thrombolysis or thrombectomy because they have missed the time window or do not meet the treatment criteria. In addition, there is a lack of an available tool to predict the prognosis of patients with standardized treatment. This study aimed to develop a dynamic nomogram to predict the 3-month poor outcomes in patients with AIS. METHODS: This was a retrospective multicenter study. We collected the clinical data of patients with AIS who underwent standardized treatment at the First People's Hospital of Lianyungang from 1 October 2019 to 31 December 2021 and at the Second People's Hospital of Lianyungang from 1 January 2022 to 17 July 2022. Baseline demographic, clinical, and laboratory information of patients were recorded. The outcome was the 3-month modified Rankin Scale (mRS) score. The least absolute shrinkage and selection operator regression were used to select the optimal predictive factors. Multiple logistic regression was performed to establish the nomogram. A decision curve analysis (DCA) was applied to assess the clinical benefit of the nomogram. The calibration and discrimination properties of the nomogram were validated by calibration plots and the concordance index. RESULTS: A total of 823 eligible patients were enrolled. The final model included gender (male; OR 0.555; 95% CI, 0.378–0.813), systolic blood pressure (SBP; OR 1.006; 95% CI, 0.996–1.016), free triiodothyronine (FT3; OR 0.841; 95% CI, 0.629–1.124), National Institutes of Health stroke scale (NIHSS; OR 18.074; 95% CI, 12.264–27.054), Trial of Org 10172 in Acute Stroke Treatment (TOAST; cardioembolic (OR 0.736; 95% CI, 0.396–1.36); and other subtypes (OR 0.398; 95% CI, 0.257–0.609). The nomogram showed good calibration and discrimination (C-index, 0.858; 95% CI, 0.830–0.886). DCA confirmed the clinical usefulness of the model. The dynamic nomogram can be obtained at the website: predict model (90-day prognosis of AIS patients). CONCLUSION: We established a dynamic nomogram based on gender, SBP, FT3, NIHSS, and TOAST, which calculated the probability of 90-day poor prognosis in AIS patients with standardized treatment. Frontiers Media S.A. 2023-06-15 /pmc/articles/PMC10311209/ /pubmed/37396756 http://dx.doi.org/10.3389/fneur.2023.1139446 Text en Copyright © 2023 Jiang, Xie, Zhang, Liu, Xu, Zhong, Ge, Tao, Qian, Gong and Shen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Jiang, Yi
Xie, Chunhui
Zhang, Guanghui
Liu, Mengqian
Xu, Yiwen
Zhong, Wen
Ge, Zhonglin
Tao, Zhonghai
Qian, Mingyue
Gong, Chen
Shen, Xiaozhu
Establishment of a dynamic nomogram including thyroid function for predicting the prognosis of acute ischemic stroke with standardized treatment
title Establishment of a dynamic nomogram including thyroid function for predicting the prognosis of acute ischemic stroke with standardized treatment
title_full Establishment of a dynamic nomogram including thyroid function for predicting the prognosis of acute ischemic stroke with standardized treatment
title_fullStr Establishment of a dynamic nomogram including thyroid function for predicting the prognosis of acute ischemic stroke with standardized treatment
title_full_unstemmed Establishment of a dynamic nomogram including thyroid function for predicting the prognosis of acute ischemic stroke with standardized treatment
title_short Establishment of a dynamic nomogram including thyroid function for predicting the prognosis of acute ischemic stroke with standardized treatment
title_sort establishment of a dynamic nomogram including thyroid function for predicting the prognosis of acute ischemic stroke with standardized treatment
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311209/
https://www.ncbi.nlm.nih.gov/pubmed/37396756
http://dx.doi.org/10.3389/fneur.2023.1139446
work_keys_str_mv AT jiangyi establishmentofadynamicnomogramincludingthyroidfunctionforpredictingtheprognosisofacuteischemicstrokewithstandardizedtreatment
AT xiechunhui establishmentofadynamicnomogramincludingthyroidfunctionforpredictingtheprognosisofacuteischemicstrokewithstandardizedtreatment
AT zhangguanghui establishmentofadynamicnomogramincludingthyroidfunctionforpredictingtheprognosisofacuteischemicstrokewithstandardizedtreatment
AT liumengqian establishmentofadynamicnomogramincludingthyroidfunctionforpredictingtheprognosisofacuteischemicstrokewithstandardizedtreatment
AT xuyiwen establishmentofadynamicnomogramincludingthyroidfunctionforpredictingtheprognosisofacuteischemicstrokewithstandardizedtreatment
AT zhongwen establishmentofadynamicnomogramincludingthyroidfunctionforpredictingtheprognosisofacuteischemicstrokewithstandardizedtreatment
AT gezhonglin establishmentofadynamicnomogramincludingthyroidfunctionforpredictingtheprognosisofacuteischemicstrokewithstandardizedtreatment
AT taozhonghai establishmentofadynamicnomogramincludingthyroidfunctionforpredictingtheprognosisofacuteischemicstrokewithstandardizedtreatment
AT qianmingyue establishmentofadynamicnomogramincludingthyroidfunctionforpredictingtheprognosisofacuteischemicstrokewithstandardizedtreatment
AT gongchen establishmentofadynamicnomogramincludingthyroidfunctionforpredictingtheprognosisofacuteischemicstrokewithstandardizedtreatment
AT shenxiaozhu establishmentofadynamicnomogramincludingthyroidfunctionforpredictingtheprognosisofacuteischemicstrokewithstandardizedtreatment